| Dr Kyle B Basham, MD | |
|
5500 Ellsworth Rd, Fort Smith, AR 72903-3222 | |
| (479) 709-7295 | |
| (479) 709-7296 |
| Full Name | Dr Kyle B Basham |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 12 Years |
| Location | 5500 Ellsworth Rd, Fort Smith, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043573355 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | E-10368 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health - Fort Smith | Fort smith, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Services | 0648514133 | 128 |
News Archive
Nektar Therapeutics today announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is Nektar's investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers.
It is not uncommon to find aluminum in municipal water systems. It's part of a treatment chemical used in some water treatment processes. Recently, however, it has been discovered in lead scale, deposits that form on lead water pipes.
As part of its ongoing work on biocompatibility and bioactivity of Hydroxyapatite (HA), Ceram, the materials technology company, has published a new white paper, ‘Multi-Substituted Hydroxyapatites and the Role They Can Play in Enhanced Bone Replacement Solutions'.
A research letter by Mary R. L'Abbe, Ph.D., of the University of Toronto, Canada, and colleagues examined the nutritional profile of breakfast, lunch, and dinner meals from sit-down restaurants.
Nancy Lindborg, USAID's assistant administrator for the Bureau for Democracy, Conflict and Humanitarian Assistance, writes in this post in USAID's "IMPACTblog" that the U.S. "continues to call on all parties involved to allow unfettered humanitarian access to Somalis in need."
› Verified 8 days ago
| Entity Name | Fort Smith Hma Pbc Management Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477888907 PECOS PAC ID: 8224172127 Enrollment ID: O20100216000383 |
News Archive
Nektar Therapeutics today announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is Nektar's investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers.
It is not uncommon to find aluminum in municipal water systems. It's part of a treatment chemical used in some water treatment processes. Recently, however, it has been discovered in lead scale, deposits that form on lead water pipes.
As part of its ongoing work on biocompatibility and bioactivity of Hydroxyapatite (HA), Ceram, the materials technology company, has published a new white paper, ‘Multi-Substituted Hydroxyapatites and the Role They Can Play in Enhanced Bone Replacement Solutions'.
A research letter by Mary R. L'Abbe, Ph.D., of the University of Toronto, Canada, and colleagues examined the nutritional profile of breakfast, lunch, and dinner meals from sit-down restaurants.
Nancy Lindborg, USAID's assistant administrator for the Bureau for Democracy, Conflict and Humanitarian Assistance, writes in this post in USAID's "IMPACTblog" that the U.S. "continues to call on all parties involved to allow unfettered humanitarian access to Somalis in need."
› Verified 8 days ago
| Entity Name | Baptist Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922587690 PECOS PAC ID: 0648514133 Enrollment ID: O20181211001401 |
News Archive
Nektar Therapeutics today announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is Nektar's investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers.
It is not uncommon to find aluminum in municipal water systems. It's part of a treatment chemical used in some water treatment processes. Recently, however, it has been discovered in lead scale, deposits that form on lead water pipes.
As part of its ongoing work on biocompatibility and bioactivity of Hydroxyapatite (HA), Ceram, the materials technology company, has published a new white paper, ‘Multi-Substituted Hydroxyapatites and the Role They Can Play in Enhanced Bone Replacement Solutions'.
A research letter by Mary R. L'Abbe, Ph.D., of the University of Toronto, Canada, and colleagues examined the nutritional profile of breakfast, lunch, and dinner meals from sit-down restaurants.
Nancy Lindborg, USAID's assistant administrator for the Bureau for Democracy, Conflict and Humanitarian Assistance, writes in this post in USAID's "IMPACTblog" that the U.S. "continues to call on all parties involved to allow unfettered humanitarian access to Somalis in need."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kyle B Basham, MD 11001 Executive Center Dr Ste 200, Little Rock, AR 72211-4393 Ph: (479) 709-7295 | Dr Kyle B Basham, MD 5500 Ellsworth Rd, Fort Smith, AR 72903-3222 Ph: (479) 709-7295 |
News Archive
Nektar Therapeutics today announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is Nektar's investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers.
It is not uncommon to find aluminum in municipal water systems. It's part of a treatment chemical used in some water treatment processes. Recently, however, it has been discovered in lead scale, deposits that form on lead water pipes.
As part of its ongoing work on biocompatibility and bioactivity of Hydroxyapatite (HA), Ceram, the materials technology company, has published a new white paper, ‘Multi-Substituted Hydroxyapatites and the Role They Can Play in Enhanced Bone Replacement Solutions'.
A research letter by Mary R. L'Abbe, Ph.D., of the University of Toronto, Canada, and colleagues examined the nutritional profile of breakfast, lunch, and dinner meals from sit-down restaurants.
Nancy Lindborg, USAID's assistant administrator for the Bureau for Democracy, Conflict and Humanitarian Assistance, writes in this post in USAID's "IMPACTblog" that the U.S. "continues to call on all parties involved to allow unfettered humanitarian access to Somalis in need."
› Verified 8 days ago
Dr. John Leslie Lange, M.D. Urology Medicare: Medicare Enrolled Practice Location: 5500 Ellsworth Rd., Fort Smith, AR 72903 Phone: 479-242-2411 Fax: 479-242-2412 | |
John D. Terrell, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 5500 Ellsworth Rd, Fort Smith, AR 72903 Phone: 479-494-9524 Fax: 479-226-5784 | |
Dr. Gerald Eugene Wahman, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 5500 Ellsworth Rd., Fort Smith, AR 72903 Phone: 479-242-2411 Fax: 479-242-2412 | |
Dr. Sinclair W Armstrong Jr., MD Urology Medicare: Not Enrolled in Medicare Practice Location: 7001 Rogers Ave, Fort Smith, AR 72903 Phone: 479-452-2077 | |
Dr. Darryl R Francis Ii, MD Urology Medicare: Medicare Enrolled Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-2000 | |
Dr. Ronald P. Knobloch, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5500 Ellsworth Rd., Fort Smith, AR 72903 Phone: 479-242-2411 Fax: 479-242-2412 |